Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis

NCT02778828 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Linezolid

Sponsor

Fondation Hôpital Saint-Joseph